<DOC>
	<DOC>NCT03028077</DOC>
	<brief_summary>This study was conducted to investigate the effects of daily supplementation of GS-3K8 or GINst15 on acute respiratory illness (ARI) in healthy subjects.</brief_summary>
	<brief_title>Effects of GS-3K8 and GINst15 on Acute Respiratory Illness</brief_title>
	<detailed_description>This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Forty five subjects were randomly divided into GS-3K8 (Ultrafiltered red ginseng extract) or GINst15 (Hydrolyzed ginseng extract) or placebo group. The primary clinical outcome measure was the incidence of ARI. The secondary clinical outcome measure was the development and duration of ARI symptoms.</detailed_description>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>Age 3965 years with healthy adults Subjects had been vaccinated against influenza in the previous 6 months Subjects with symptoms of upper respiratory tract infection Subjects with acute/chronic disease History of alcohol or substance abuse History of disease that could interfere with the test products or impede their absorption Subjects taking medications such as immune or upper respiratory tract infection related drug or functional foods Abnormal liver or kidney function tests Pregnant or lactating women and heavy smokers Being judged by the responsible physician of the local study center as unfit to participate in the study</criteria>
	<gender>All</gender>
	<minimum_age>39 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>ultrafiltered red ginseng</keyword>
	<keyword>hydrolyzed ginseng</keyword>
	<keyword>acute respiratory illness</keyword>
	<keyword>clinical trial</keyword>
</DOC>